These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8703242)

  • 1. A comparative study of tuberculin skin test reactivity between asymptomatic HIV-1 seropositive subjects and healthy volunteers.
    Suwanagool S; Chuenarom V; Pechthanon L; Sonjai A; Leelarasamee A; Pathrakom C
    Asian Pac J Allergy Immunol; 1995 Dec; 13(2):139-44. PubMed ID: 8703242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
    Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
    JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients.
    Diagbouga S; Fumoux F; Ledru E; Sanou PT; Barro D; Marchal G
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):317-23. PubMed ID: 9559403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok.
    Hiransuthikul N; Hanvanich M; Dore GJ; Mokkhawes T; Li Y; Perriens J; Kaldor JM
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):804-9. PubMed ID: 15115092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.
    Markowitz N; Hansen NI; Wilcosky TC; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Osmond D; Wallace JM; Rosen MJ; Reichman LB
    Ann Intern Med; 1993 Aug; 119(3):185-93. PubMed ID: 8100692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.
    Janis EM; Allen DW; Glesby MJ; Carey LA; Mundy LM; Gopalan R; Chaisson RE
    Am J Med; 1996 Feb; 100(2):186-92. PubMed ID: 8629653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
    Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH
    N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS).
    Anastos K; Kalish LA; Palacio H; Benson CA; Delapenha R; Chirgwin K; Stonis L; Telzak EE
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):141-7. PubMed ID: 10360806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association of induration size with HIV infection among drug users reacting to tuberculin.
    Gourevitch MN; Hartel D; Schoenbaum EE; Klein RS
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1029-33. PubMed ID: 8887602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mantoux intradermal reaction and lymphocyte populations in asymptomatic HIV-seropositive subjects].
    Canessa PA; Torraca A; Mattei G
    Medicina (Firenze); 1990; 10(4):394-6. PubMed ID: 1983096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
    Portu JJ; Aldamiz-Etxebarria M; Agud JM; Arévalo JM; Almaraz MJ; Ayensa C
    Addict Biol; 2002 Apr; 7(2):235-41. PubMed ID: 12006219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
    Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculin skin test reactivity among adults infected with human immunodeficiency virus.
    Johnson MP; Coberly JS; Clermont HC; Chaisson RE; Davis HL; Losikoff P; Ruff AJ; Boulos R; Halsey NA
    J Infect Dis; 1992 Jul; 166(1):194-8. PubMed ID: 1607696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of positive tuberculin reactions in women with or at risk for HIV-1 infection. HER Study Group. HIV Epidemiology Research.
    Klein RS; Smith D; Sobel J; Flanigan T; Margolick JB
    Int J Tuberc Lung Dis; 2000 Jul; 4(7):688-92. PubMed ID: 10907773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of Bacillus Calmette-Guerin vaccine in children born to HIV-1 infected women.
    Thaithumyanon P; Thisyakorn U; Punnahitananda S; Praisuwanna P; Ruxrungtham K
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):482-6. PubMed ID: 11289006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel.
    García-García ML; Valdespino-Gómez JL; García-Sancho C; Mayar-Maya ME; Palacios-Martínez M; Balandrano-Campos S; Escobar-Gutiérrez A; Peruga A; Weissenbacher M; Daniels E
    Int J Epidemiol; 2000 Apr; 29(2):369-75. PubMed ID: 10817138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.